HFrEF患者再同步化后超反应因素探讨  

Actors of overreaction after resynchronization in heart failure patients with reduced ejection fraction

作　　者：李爱伟[1] 杨秀艳[1] 夏英杰[1] Li Aiwei;Yang Xiuyan;Xia Yingjie(The First People's Hospital of Tangshan,063000)

机构地区：[1]唐山市人民医院,063000

出　　处：《现代科学仪器》2022年第5期96-100,共5页Modern Scientific Instruments

基　　金：2019年度河北医学科学研究课题计划,20191586。

摘　　要：目的:分析HFrEF患者经心脏再同步化治疗后超反应的相关因素。方法:收集2018年5月~2019年10月我院收治的100例HFrEF患者的资料,分为超反应组(30例)、非超反应组(70例)。分析HFrEF患者经心脏再同步化治疗后超反应的相关因素。结果:病程短、非缺血性心肌病、双心室起搏比例高、RA短是HFrEF患者经心脏再同步化治疗后超反应的危险因素(OR=5.114;15.425;14.644;13.846,P<0.05)。结论:HFrEF患者经心脏再同步化治疗后发生超反应的相关因素包括病程短、非缺血性心肌病、双心室起搏比例高、RA短等。Objective:To analyze the related factors of hyperreaction in patients with HFrEF after cardiac resynchronization therapy.Methods:The data of 100 patients with HFrEF from May 2018 to October 2019 in our hospital were collected and divided into hyperreaction group(30 cases)and non-hyperreaction group(70 cases).To analyze the related factors of hyperreaction in HFrEF patients after cardiac resynchronization therapy.Results:Short course of disease,non-ischemic cardiomyopathy,high biventricular pacing rate and short RA were the risk factors of hyperreaction in HFrEF patients after cardiac resynchronization therapy(OR=5.114;15.425;14.644;13.846,P<0.05).Conclusion:The related factors of hyperreaction in HFrEF patients after cardiac resynchronization therapy included short course of disease,non-ischemic cardiomyopathy,high biventricular pacing rate,short RA,etc.

关 键 词：心力衰竭 射血分数 心脏再同步化 心电图 心脏超声 超反应 相关因素 

分 类 号：R541.6[医药卫生—心血管疾病]